Medifast reports Q3 EPS (21c), one estimate (36c)

Reports Q3 revenue $89.4M, one estimate $89.7M. “We’re transforming Medifast (MED) from a weight-loss company into a leader in promoting metabolic health,” said Dan Chard, Chairman and Chief Executive Officer of Medifast. “Our clinically proven, coach-guided system does more than help people lose weight-it addresses the underlying metabolic dysfunction that drives most health challenges. This strategic evolution positions us in a larger, more durable market with strong consumer tailwinds. It’s a transformation founded in proven science that creates meaningful health outcomes. With a strong balance sheet, a passionate coach community, and clinically proven plans, we believe Medifast is well positioned to become the trusted partner for millions seeking metabolic health.”